Presynaptic neuropeptide receptors

Handbook of Experimental Pharmacology

Volumn 184, Issue , 2008, Pages 409-434

  Schlicker, E ^a   Kathmann, M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y RECEPTOR; OPIATE RECEPTOR; OREXIN RECEPTORS; PRESYNAPTIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; REVIEW;

ANIMALS; HUMANS; NEUROPEPTIDES; RECEPTORS, CORTICOTROPIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, OPIOID; RECEPTORS, PRESYNAPTIC;

EID: 39349107671     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-74805-2_13     Document Type: Article

References (129)

1. Abrahamsson C (2000) Neuropeptide Y1-and Y2-receptor-mediated cardiovascular effects in the anaesthetized guinea pig, rat, and rabbit. J Cardiovasc Pharmacol 36:451-8
2. Ackley MA, Hurley RW, Virnich DE et al (2001) A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist. Pain 91:377-88
3. Aimone LD, Yaksh TL (1989) Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo. Peptides 10:1127-31
4. Alexander SPH, Mathie A, Peters JA (2006) Guide to receptors and channels, 2nd edition. Br J Pharmacol 147 (Suppl 3) :S1-S180
5. Allen JM, Adrian TE, Tatemoto K et al (1982) Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides 3:71-7
6. Allgaier C, Daschmann B, Sieverling J et al (1989) Presynaptic opioid receptors on noradrenergic nerve terminals couple to G-proteins and interact with α2-adrenoceptors. J Neurochem 53:1629-35
7. Averbeck B, Reeh PW, Michaelis M (2001) Modulation of CGRP and PGE2 release from isolated rat skin by alpha-adrenoceptors and kappa-opioid- receptors. Neuroreport 12:2097-2100
8. Barral J, Mendoza E, Galarraga E et al (2003) The presynaptic modulation of corticostriatal afferents by opioids is mediated by K+ conductances. Eur J Pharmacol 462:91-8
9. Beani L, Bianchi C, Siniscalchi A (1982) The effect of naloxone on opioid-induced inhibition and facilitation of acetylcholine release in brain slices. Br J Pharmacol 76:393-401
10. Berger B, Rothmaier AK, Wedekind F et al (2006) Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br J Pharmacol 148:795-806
11. Bergevin A, Girardot D, Bourque MJ et al (2002) Presynaptic opioid receptors regulate a late step of the secretory process in rat ventral tegmental area GABAergic neurons. Neuropharmacology 42:1065-78
12. Blakemore LJ, Levenson CW, Trombley PQ (2006) Neuropeptide Y modulates excitatory synaptic transmission in the olfactory bulb. Neuroscience 138:663-74
13. Bloch B, Bugnon C, Fellmann D, Lenys D, Gouget A (1979) Neurons of the rat hypothalamus reactive with antisera against endorphins, ACTH, MSH and ß-LPH. Cell Tissue Res 204:1-15
14. Boehm S, Kubista H (2002) Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54:43-99
15. Bouryi VA, Lewis DI (2004) Enkephalinergic inhibition of raphe pallidus inputs to rat hypoglossal motoneurones in vitro. Neuroscience 129:55-64
16. Brain SD, Cox HM (2006) Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 147:S202-S211
17. Browning KN, Kalyuzhny AE, Travagli RA (2002) Opioid peptides inhibit excitatory but not inhibitory synaptic transmission in the rat dorsal motor nucleus of the vagus. J Neurosci 22:2998-3004
18. Bugnot C, Bloch B, Lenys D, Fellmann D (1979) Infundibular neurons of the human hypothalamus simultaneously reactive with antisera against endorphins, ACTH, MSH, and beta-LPH. Cell Tissue Res 199:177-96
19. Burlet S, Tyler CJ, Leonard CS (2002) Direct and indirect excitation of laterodorsal temental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22: 2862-72
20. Capogna M, Gahwiler BH, Thompson SM (1993) Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J Physiol 470:539-58
21. Chemelli RM, Willie JT, Sinton CM et al (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-51
22. Cherubini E, North RA (1985) Mu and kappa opioids inhibit transmitter release by different mechanisms. Proc Natl Acad Sci 82:1860-3
23. Collip JB, Anderson EM, Thomson DL (1933) The adrenotropic hormone of the anterior pituitary lobe. Lancet 222:347-8
24. Cosentino M, Marino F, De Ponti F et al (1995) Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: effect of mu and kappa opioid receptor blockade and of chronic sympathetic denervation. Neurosci Lett 194:185-8
25. Costa M, Majewski H (1988) Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, ß-adrenoceptors and angiotensin II receptors. Br J Pharmacol 95:993-1001
26. Davis SF, Williams KW, Xu W (2003) Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation. J Neurosci 23: 3844-54
27. de Lecea L, Kilduff T, Peyron C et al (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci 95:322-7
28. Emmerson PJ, Miller RJ (1999) Pre-and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro. J Physiol 517:431-45
29. Endo K, Yawo H (2000) mu-Opioid receptor inhibits N-type Ca2+ channels in the calyx presynaptic terminal of the embryonic chick ciliary ganglion. J Physiol 524:769-81
30. Feuerstein TJ, Gleichauf O, Peckys D et al (1996) Opioid receptor-mediated control of acetylcholine release in human neocortex tissue. Naunyn-Schmiedeberg's Arch Pharmacol 354:586-92
31. Finnegan TF, Chen SR, Pan HL (2005) Effect of the ? opioid on excitatory and inhibitory synaptic inputs to periqueductal gray-projecting neurons in the amygdala. J Pharmacol Exp Ther 312:441-8
32. Finnegan TF, Chen SR, Pan HL (2006) Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1. 1/1. 2 channels. J Neurophysiol 95:2032-41
33. Fu LY, Acuna-Goycolea C, van den Pol (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24:8741-51
34. Gannon RL, Terrian DM (1991) U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals. Brain Res 548:242-7
35. Gantz I, Fong JM (2003) The melanocortin system. Am J Physiol Endocrinol Metabol 284:E468-E474
36. Glatzer NR, Smith BN (2005) Modulation of synaptic transmission in the rat nucleus of the solitary tract by endomorphin-1. J Neurophysiol 93:2530-40
37. Glaum SR, Miller RJ, Hammond DL (1994) Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J Neurosci 14:4965-71
38. Go VLW, Yaksh TL (1987) Release of substance P from the cat spinal cord. J Physiol (Lond) 391:141-67
39. Gothert M (1981) ACTH1-24 increases stimulation-evoked noradrenaline release from sympathetic nerves by acting on presynaptic ACTH receptors. Eur J Pharmacol 76:295-6
40. GothertM (1984) Facilitatory effect of adrenocorticotropic hormone and related peptides on Ca2+-dependent noradrenaline release from sympathetic nerves. Neuroscience 11:1001-9
41. Gothert M, Hentrich F (1984) Role of cAMP for regulation of impulse-evoked noradrenaline release from the rabbit pulmonary artery and its possible relationship to presynaptic ACTH receptors. Naunyn-Schmiedeberg's Arch Pharmacol 328:127-34
42. Grudt TJ, Henderson G (1998) Glycine and GABAA receptor-mediated synaptic transmission in rat substantia gelatinosa: inhibition by mu-opioid and GABAB agonists. J Physiol 507:473-83
43. Guarraci FA, Pozo MJ, Palomares SM et al (2002) Opioid agonists inhibit excitatory neurotransmission in ganglia and at the neuromuscular junction in guinea pig gallbladder. Gastroenterology 122:340-51
44. Guerrini R, Calo G, Rizzi A et al (1998) A new selective antagonist of the nociceptin receptor. Brit J Pharmacol 123:163-5
45. Gutstein HB, Akil H (2006) Opioid analgesics. In: Brunton LL (ed) Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp 547-90
46. Hahm ET, Lee JJ, Min BI et al (2004) Opioid inhibition of GABAergic neurotransmission in mechanically isolated rat periqueductal gray neurons. Neurosci Res 50:343-54
47. Hayar A, Guyenet PG (1998) Pre-and postsynaptic inhibitory actions of methonine-enkephalin on identified bulbospinal neurons of the rat RVL. J Neurophysiol 80:2003-14
48. Hjelmstadt GO, Fields HL (2001) Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell. J Neurophysiol 85:1153-8
49. Ho M, Corbett AD, McKnight AT (2000) Characterization of the ORL1 receptor on adrenergic nerves in the rat anococcygeus muscle. Br J Pharmacol 131:349-55
50. Honda E, Ono K, Inenaga K (2004) DAMGO suppresses both excitatory and inhibitory synaptic transmission in supraoptic neurones of mouse hypothalamic slice preparations. J Neuroendocrinol 16:198-207
51. Hughes J, Smith TW, Kosterlitz HW et al (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577-9
52. Illes P (1989) Modulation of transmitter and hormone release by multiple neuronal opioid receptors. Rev Physiol Biochem Pharmacol 112:141-233
53. Jackisch R (1991) Regulation of neurotransmitter release by opiates and opioid peptides in the central nervous system. In: Feigenbaum J, Hanani M (eds) Presynaptic regulation of neurotransmitter release: a handbook. Freund Publishing House, Tel Aviv, pp 551-92
54. Johnston MF, Kravitz EA, Meiri H et al (1983) Adrenocorticotropic hormone causes long-lasting potentiation of transmitter release from frog motor nerve terminals. Science 220:1071-2
55. Katayama Y, Homma T, Honda K et al (2003) Actions of orexin A in the myenteric plexus of the guinea-pig small intestine. Neuroreport 14:1515-18
56. Katayama Y, Hirai K, Homma T et al (2005) Actions of orexins on individual myenteric neurons of the guinea-pig ileum: orexin A or B? Neuroreport 16:745-9
57. Kennedy C, Krier J (1987) Opioid receptors mediate inhibition of fast excitatory postsynaptic potentials in cat parasympathetic colonic ganglia. Br J Pharmacol 92:437-43
58. Kerchner GA, Zhuo M (2002) Presynaptic suppression of dorsal horn inhibitory transmission by mu-opioid receptors. J Neurophysiol 88:520-2
59. King PJ, Williams G, Doods H et al (2000) Effect of a selective neuropeptide Y Y2 receptor antagonist BIIE 0246 on neuropeptide Y release. Eur J Pharmacol 396:1-3
60. Kishimoto K, Koyama S, Akaike N (2001) Synergistic mu-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons. Neuropharmacology 41:529-38
61. Klapstein GJ, Colmers WF (1992) 4-Aminopyridine and low Ca2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br J Pharmacol 105:470-4
62. Lambe E, Aghajanian GK (2003) Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified the boutons in prefrontal slice. Neuron 40:139-50
63. Li Y, Gao XB, Sakurai T et al (2002) Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-a potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36:1169-81
64. Lin L, Faraco J, Li R et al (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-76
65. Liu QS, Han S, Jia YS et al (1999) Selective modulation of excitatory transmission by mu-opioid receptor activation in rat supraoptic neurons. J Neurophysiol 82:3000-5
66. Liu S, Hu HZ, Ren J et al (2001) Pre-and postsynaptic inhibition by nociceptin in guinea pig small intestinal myenteric plexus in vitro. Am J Physiol Gastrointest Liver Physiol 281:G237-G246
67. Mahns DA, Lacroix JS, Potter EK (1998) Inhibition of vagal vasodilatation by a selective neuropeptide YY2 receptor agonist in the bronchial circulation of anaesthetised dogs. J Auton Nerv Syst 73:80-5
68. Miller RJ (1998) Presynaptic receptors. Annu Rev Pharmacol Toxicol 38:201-27
69. Modin A, Pernow J, Lundberg JM (1994) Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs. J Auton Nerv Syst 49:123-34
70. Moran TD, Colmers WF, Smith PA (2004) Opioid-like actions of neuropeptide Y in rat substantia gelatinosa: Y1 suppression of inhibition and Y2 suppression of excitation. J Neurophysiol 92:3266-75
71. Morris MJ (2004) Neuropeptide Y and cardiovascular function. In: Michel MC (ed) Neuropeptide Y and related peptides, Handbook of Experimental Pharmacology, vol 162. Springer, Berlin, pp 327-59
72. Mulder AH, Schoffelmeer ANM (1993) Multiple opioid receptors and presynaptic modulation of neurotransmitter release in the brain. In: Herz A (ed) Opioids I, Handbook of Experimental Pharmacology, vol 104/I. Springer, Berlin, pp 125-44
73. Nakazi M (2001) Hemmung der Serotoninfreisetzung im Mausegehirn durch Cannabinoid-CB1-Rezeptoren und andere Rezeptorsysteme. Thesis, University of Bonn
74. Nakazi M, Bauer U, Nickel T et al (2000) Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 361:19-24
75. Nicholson JR, Paterson SJ, Menzies JRW et al (1998) Pharmacological studies on the orphan opioid receptor in central and peripheral sites. Can J Physiol Pharmacol 76:304-13
76. Nikolarakis KE, Almeida OF, Yassouridis A et al (1989) Presynaptic auto-and allelo-receptor regulation of hypothalamic opioid peptide release. Neuroscience 31:269-73
77. Odar-Cederlof I, Ericsson F, Theodorsson E et al (2003) Neuropeptide-Y and atrial natriuretic peptide as prognostic markers in patients on hemodialysis. ASAIO J 49:74-80
78. Ogura M, Kita H (2000) Dynorphin exerts both postsynaptic and presynaptic effects in the Globus pallidus of the rat. J Neurophysiol 83:3366-76
79. Ostermeier AM, Schlosser B, Schwender D et al (2000) Activation of mu-and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons. Anesthesiology 93:1053-63
80. Pan YZ, Li DP, Chen SR et al (2002) Activation of delta-opioid receptors excites spinally projecting locus coeruleus neurons through inhibition of GABAergic inputs. J Neurophysiol 88:2675-83
81. Pan YZ, Li DP, Chen SR et al (2004) Activation of mu-opioid receptors excites a population of locus coeruleus-spinal neurons through presynaptic disinhibition. Brain Res 997:67-78
82. Potter EK, Tripovic D (2006) Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs. Exp Brain Res 173:346-52
83. Qian J, Colmers WF, Saggau P (1997) Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J Neurosci 17:8169-77
84. Rhim H, Kinney GA, Emmerson PJ et al (1997) Regulation of neurotransmission in the arcuate nucleus of the rat by different neuropeptide Y receptors. J Neurosci 17:2980-9
85. Rogers H, Henderson G (1990) Activation of mu-and delta-opioid receptors present on the same nerve terminals depresses transmitter release in the mouse hypogastric ganglion. Brit J Pharmacol 101:505-12
86. Rominger A, Forster S, Zentner J et al (2002) Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices. Br J Pharmacol 135:800-6
87. Sandor NT, Kiss J, Sandor A et al (1991) Naloxone enhances the release of acetylcholine from cholinergic interneurons of the striatum if the dopaminergic input is impaired. Brain Res 552:343-5
88. Schlicker E, KathmannM (2000) Modulation of the release of noradrenaline and other transmitters via cannabinoid and opioid receptors. Fundam Clin Pharmacol 14:64
89. Schlicker E, Morari M (2000) Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides 21:1023-9
90. Schlicker E, Werthwein S, Kathmann M et al (1998) Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 358:418-22
91. Schlosser B, Kudernatsch MB, Sutor B et al (1995) Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices. Neurosci Lett 191:126-30
92. Schwertfeger E, Klein T, Vonend O et al (2004) Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 369:455-61
93. Serone AP, Wright CE, Angus JA (1999) Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission. Brit J Pharmacol 127:99-108
94. Shen KZ, Johnson SW (2002) Presynaptic modulation of synaptic transmission by opioid receptor in rat subthalamic nucleus in vitro. J Physiol 541:219-30
95. Simmoneaux V, Ouichou A, Craft C et al (1994) Presynaptic and postsynaptic effects of neuropeptide Y in the rat pineal gland. J Neurochem 62:2464-71
96. Simmons ML, Terman GW, Drake CT et al (1994) Inhibition of glutamate release by presynaptic kappa 1-opioid receptors in the guinea pig dentate gyrus. J Neurophysiol 72:1697-1705
97. Smart D, Jerman JC (2002) The physiology and pharmacology of the orexins. Pharmacol Ther 94:51-61
98. Smith BN, Davis SF, van den Pol AN et al (2002) Selective enhancement of excitatory synaptic activity in the rat nucleus tractus solitarius by hypocretin 2. Neuroscience 115:707-14
99. Smith-White MA, Herzog H, Potter EK (2002) Role of neuropeptide Y Y2 receptors in modulation of cardiac parasympathetic neurotransmission. Regul Peptides 103:105-11
100. Stanford IM, Cooper AJ (1999) Presynaptic mu and delta opioid receptor modulation of GABAA IPSCs in the rat globus pallidus in vitro. J Neurosci 19:4796-4803
101. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1-124
102. Stjarne L, Stjarne E, Mshgina M (1989) Does clonidine or neuropeptide Y-mediated inhibition of ATP secretion from sympathetic nerves operate primarily by increasing a potassium conductance? Acta Physiol Scand 136:137-8
103. Storr M, Hahn A, Gaffal E et al (2002) Effects of endomorphin-1 and-2 on on mu-opioid receptors in myenteric neurons and in the peristaltic reflex in rat small intestine. Clin Exp Pharmacol Physiol 29:428-34
104. Sun QQ, Akk G, Huguenard JR et al (2001) Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1 and Y2 receptors in rat thalamic neurons. J Physiol 531:81-94
105. Szabo B Hedler L, Lichtwald K et al (1987) ACTH increases noradrenaline release in pithed rabbits with electrically stimulated sympathetic outflow. Eur J Pharmacol 136:391-9
106. Szabo B, Hedler L, Schurr C et al (1988) ACTH increases noradrenaline release in the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 338:368-72
107. Szabo B, Hedler L, Starke K (1989) Facilitation of the release of noradrenaline: an extra-adrenal effect of adrenocorticotropic hormone. Resuscitation 18:229-42
108. Tatemoto K (2004) Neuropeptide Y: history and overview. In: Michel MC (ed) Neuropeptide Y and related peptides, Handbook of Experimental Pharmacology, vol 162. Springer, Berlin, pp 1-21
109. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659-60
110. Taube HD, Borowski E, Endo T et al (1976) Enkephalin: a potential modulator of noradrenaline release in rat brain. Eur J Pharmacol 38:377-80
111. Thannickal TC, Moore RY, Nienhuis R (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-74
112. Trendelenburg P (1917) Physiologische und pharmakologische Versuche uber die Dunndarmperistaltik. Arch Exp Pathol Pharmakol 81:55-129
113. Trendelenburg AU, Cox SL, Schelb V et al (2000) Modulation of 3H-noradrenaline release by presynaptic opoid, cannabinoid and bradykinin and ß-adrenoceptors in mouse tissues. Brit J Pharmacol 130:321-30
114. Tu B, Timofeeva O, Jiao Y et al (2005) Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J Neurosci 25:1718-29
115. Ueda H, Fukushima N, Ge M et al (1987) Presynaptic opioid kappa-receptor and regulation of the release of Met-enkephalin in the rat brainstem. Neurosci Lett 81:309-13
116. van den Pol AN, Gao XB, Obrietan K et al (1998) Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18:7962-71
117. Vaughan CW, Christie MJ (1997) Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J Physiol 498:463-72
118. Vaughan CW, Ingram SL, Christie MJ (1997) Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci 17:996-1003
119. Vezzani A, Sperk G (2004) Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy ? Neuropeptides 38:245-52
120. Wang SJ (2005) Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway. Neuroscience 134:987-1000
121. Wang X, Dergacheva O, Griffioen KJ et al (2004) Action of kappa and delta opioid agonists on premotor cardiac vagal neurons in the nucleus ambiguus. Neuroscience 129:235-41
122. Werling LL, McMahon PN, Cox BM (1989) Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices. Naunyn-Schmiedeberg's Arch Pharmacol 339:509-13
123. Westfall TC (2004) Prejunctional effects of of neuropeptide Y and its role as a cotransmitter. In: Michel MC (ed) Neuropeptide Y and related peptides, Handbook of Experimental Pharmacology, vol 162. Springer, Berlin, pp 137-83
124. Yang XP, Chiba S (2002) Antagonistic interaction between BIIE 0246, a neuropeptide Y Y2-receptor antagonist, and omega-conotoxin GVIA, a Ca2+ channel antagonist, in presynaptic transmitter releases in dog splenic arteries. Jpn J Pharmacol 89:188-91
125. Yu XJ, Moskowitz MA (1996) Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms. Br J Pharmacol 119:229-32
126. Yu TP, Fein J, Phan T et al (1997) Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 7:88-94
127. Yu Y,Wang X, Cui Y et al (2006) Abnormal modulation of cholinergic neurotransmission by endomorphin 1 and endomorphin 2 in isolated bronchus of type 1 diabetic rats. Peptides 27:2770-7
128. Zhu W, Pan ZZ (2005) Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 133:97-103
129. Zollner C, Stein C (2007) Opioids. In: Stein C (ed) Analgesia, Handbook of Experimental Pharmacology, vol 177. Springer, Berlin, pp 31-63